|
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine |
|
CHEBI:131662 |
|
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine |
|
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as (11Z,14Z)-icosadienoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C47H80NO8P/c1-3-5-7-9-11-13-15-17-19-21-22-24-26-28-30-32-34-36-38-40-47(50)56-45(44-55-57(51,52)54-42-41-48)43-53-46(49)39-37-35-33-31-29-27-25-23-20-18-16-14-12-10-8-6-4-2/h11-14,17-20,22,24,28,30,34,36,45H,3-10,15-16,21,23,25-27,29,31-33,35,37-44,48H2,1-2H3,(H,51,52)/b13-11-,14-12-,19-17-,20-18-,24-22-,30-28-,36-34-/t45-/m1/s1 |
YKGWPFOSRMGOGZ-BDJNJYPGSA-N |
C(OP(=O)(OCCN)O)[C@@H](COC(CCCCCCCCC/C=C\C/C=C\CCCCC)=O)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:131662)
has functional parent
(11Z,14Z)-icosadienoic acid
(CHEBI:73731)
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:131662)
has functional parent
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid
(CHEBI:65136)
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:131662)
has role
mouse metabolite
(CHEBI:75771)
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:131662)
is a
1,2-diacyl-sn-glycero-3-phosphoethanolamine
(CHEBI:64674)
|
|
(6Z,9Z,23R)-29-amino-26-hydroxy-20,26-dioxo-21,25,27-trioxa-26λ5-phosphanonacosa-6,9-dien-23-yl (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate
|
1-Eicosadienoyl-2-docosapentaenoyl-sn-glycero-3-phosphoethanolamine
|
HMDB
|
GPEtn(20:2/22:5)
|
HMDB
|
GPEtn(20:2n6/22:5n6)
|
HMDB
|
GPEtn(20:2w6/22:5w6)
|
HMDB
|
GPEtn(42:7)
|
HMDB
|
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
|
ChEBI
|
PE(20:2/22:5)
|
HMDB
|
PE(20:2n6/22:5n6)
|
HMDB
|
PE(20:2w6/22:5w6)
|
HMDB
|
PE(42:7)
|
HMDB
|
Phosphatidylethanolamine(20:2/22:5)
|
HMDB
|
Phosphatidylethanolamine(20:2n6/22:5n6)
|
HMDB
|
Phosphatidylethanolamine(20:2w6/22:5w6)
|
HMDB
|
Phosphatidylethanolamine(42:7)
|
HMDB
|
27471436
|
PubMed citation
|
Europe PMC
|
|